Fatigue and proinflammatory cytokine activity in breast cancer survivors

Psychosomatic Medicine

Volumn 64, Issue 4, 2002, Pages 604-611

  Bower, Julienne E ^a   Ganz, Patricia A ^a   Aziz, Najib ^a   Fahey, John L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cortisol; Fatigue; Proinflammatory cytokines; Sickness behavior

Indexed keywords

CYTOKINE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEOPTERIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATIGUE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; IMMUNOREACTIVITY; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL;

EID: 0036071176     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-200207000-00010     Document Type: Article

References (51)

1. Off-treatment fatigue in breast cancer survivors: A controlled comparison
2. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer
3. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life
4. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer
5. Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory
6. Fatigue syndrome due to localized radiation
7. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy
8. The role of cytokines in the development of normal-tissue reactions after radiotherapy
9. Behavioral effects of cytokines: An insight into mechanisms of sickness behavior
10. Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer
11. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
12. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer
13. Fatigue linked to plasma cytokines in patients with lung cancer undergoing combined modality therapy
14. Interleukin-1 and interleukin-1 antagonism
15. Interleukin-1 receptor antagonist: Role in biology
16. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis
17. Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
18. Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells
19. Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: Long-term increase of activated (HLA-DR+) T cells and decrease of "naïve" (CD4-CD45RA) T lymphocytes
20. Adjuvant radiation therapy compared with cyclic chemotherapy in patients with mammary carcinoma
21. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine, and immune interactions
22. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms
23. Hypoimmune fatigue syndromes: Diseases of the stress response?
24. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors
25. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning
26. The RAND 36-Item Health Survey 1.0
27. A 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection
28. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality control procedures
29. Variables that affect assays for plasma cytokines and soluble activation markers
30. Base-line quality of life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention trial
31. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition
32. Increased serum IL-6 and interleukin-1 receptor antagonist concentrations in major depression and treatment resistant depression
33. Increased serum interleukin-1-receptor-antagonist concentrations in major depression
34. Biological basis of the sickness behavior of animals
35. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in HIV infection
36. Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis
37. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy
38. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome
39. Inflammation, depressive symptomatology, and coronary artery disease
40. Cytokine-associated emotional and cognitive disturbances in humans
41. Depression and immunity: A meta-analytic review
42. The role of CRF in the pathophysiology of affective disorders: Laboratory and clinical studies
43. Diurnal cortisol rhythm as a predictor of breast cancer survival
44. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome
45. Socioeconomic status and health
46. Toward understanding the association of socioeconomic status and health: A new challenge for the biopsychosocial approach
47. Vulnerability and social class: Differential patterns of personality and social support over social classes
48. Social support and social structure: A descriptive epidemiology
49. Stress and immunity and humans: A metaanalytic review
50. The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health